Package 68462-681-60

{"route": ["ORAL"], "spl_id": "a496c733-ce38-4566-83f9-0287506f4506", "openfda": {"nui": ["N0000008486"], "upc": ["0368462681602", "0368462679609", "0368462678602", "0368462680605"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (68462-681-10)", "package_ndc": "68462-681-10", "marketing_start_date": "20220318"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68462-681-30)", "package_ndc": "68462-681-30", "marketing_start_date": "20220318"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68462-681-60)", "package_ndc": "68462-681-60", "marketing_start_date": "20220318"}], "brand_name": "lacosamide", "product_id": "68462-681_a496c733-ce38-4566-83f9-0287506f4506", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-681", "dea_schedule": "CV", "generic_name": "lacosamide", "labeler_name": "Glenmark Pharmaceuticals Inc. USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "200 mg/1"}], "application_number": "ANDA205006", "marketing_category": "ANDA", "marketing_start_date": "20220318", "listing_expiration_date": "20261231"}